Breaking News Headlines Today

News about Alzheimer's Disease

Stay current with all the latest and breaking news about Alzheimer's Disease, compare headlines and perspectives between news sources on stories happening today. In total, 676 stories have been published about Alzheimer's Disease which Ground News has aggregated in the past 3 months.

Covered Most By

Medical Xpress

Center

Knowridge Science Report

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Alzheimer's Disease News

Novo Nordisk · Denmark

Novo Nordisk says Alzheimer's drug trial fails, hammering shares

61% Center coverage: 66 sources

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer's patients, sending its share price down 10%.See the Story

Alzheimer's Disease · West Virginia

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

54% Center coverage: 24 sources

See the Story

Alzheimer's Disease

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

54% Center coverage: 24 sources

Alzheimer's Disease · West Virginia See the Story

Oral Semaglutide Does Not Halt Alzheimer's Disease in Phase 3 Trials

Copenhagen – Daily oral administration of the GLP-1 agonist semaglutide did not halt the progression of dementia in people with Alzheimer's disease in two Phase 3 trials. However, some biomarkers of the disease did improve. The manufacturer, Novo Nordisk, has now announced the discontinuation of the evoke and evoke+ trials...Alzheimer's Disease · Denmark Read Article

Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker

Share Post Share Email A widely-used diabetes and weight-loss medication has failed to slow cognitive decline in people with early Alzheimer’s disease, pharmaceutical company Novo Nordisk has announced. The company’s study tested semaglutide – sold under the brand names Ozempic and Wegovy – in people with mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Despite hopes that the drug might…Alzheimer's Disease · United Kingdom Read Article

Lecanemab: Negative Benefit Assessment for Alzheimer's Medication

100% Left coverage: 1 sources

In April, the first drug was approved for Alzheimer's disease, which could possibly affect its roots. An institute does not consider it more effective compared to the therapies available so far.Alzheimer's Disease · Cologne See the Story

Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures

BackgroundMonoclonal antibodies targeting pathological tau have repeatedly failed in Alzheimer’s disease (AD) clinical trials. Whether plasma phosphorylated tau (pTau) exhibits dynamic progression or cognitive relevance in population-based cohorts remains unclear.Methods...Alzheimer's Disease · United Kingdom Read Article

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

With FDA orphan drug approval secured, Amal and his team are preparing for phase 1 clinical trials of their small-molecule drugs in 2026. The post Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs appeared first on Advanced Science News.Alzheimer's Disease Read Article

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

100% Center coverage: 1 sources

Specific immune cells in the brain may play a crucial role in preventing the onset of Alzheimer's disease, according to a new study – a discovery that could lead to new therapies that try to coax cells into this protective state.Alzheimer's Disease Read Article

News about Alzheimer's Disease

News about Alzheimer's Disease

Covered Most By

Local News Publishers

Top Alzheimer's Disease News

Novo Nordisk says Alzheimer's drug trial fails, hammering shares

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Chris Hemsworth Fights Alzheimer's in the Family

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Why GLP-1s Won’t Be Prescribed for Alzheimer’s Anytime Soon

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Oral Semaglutide Does Not Halt Alzheimer's Disease in Phase 3 Trials

Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker

Lecanemab: Negative Benefit Assessment for Alzheimer's Medication

Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Alzheimer's Disease

Chris Hemsworth Fights Alzheimer's in the Family

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Why GLP-1s Won’t Be Prescribed for Alzheimer’s Anytime Soon

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Oral Semaglutide Does Not Halt Alzheimer's Disease in Phase 3 Trials

Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker

Lecanemab: Negative Benefit Assessment for Alzheimer's Medication

Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

News about Alzheimer's Disease

News about Alzheimer's Disease

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Alzheimer's Disease News

Novo Nordisk says Alzheimer's drug trial fails, hammering shares

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Chris Hemsworth Fights Alzheimer's in the Family

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Why GLP-1s Won’t Be Prescribed for Alzheimer’s Anytime Soon

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Oral Semaglutide Does Not Halt Alzheimer's Disease in Phase 3 Trials

Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker

Lecanemab: Negative Benefit Assessment for Alzheimer's Medication

Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Alzheimer's Disease

Chris Hemsworth Fights Alzheimer's in the Family

Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

Why GLP-1s Won’t Be Prescribed for Alzheimer’s Anytime Soon

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals: study

Oral Semaglutide Does Not Halt Alzheimer's Disease in Phase 3 Trials

Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker

Lecanemab: Negative Benefit Assessment for Alzheimer's Medication

Plasma pTau-181 Exhibits Flat Longitudinal Trajectories and Weak Cognitive Correlation in UK Biobank: Implications for Anti-Tau Antibody Trial Failures

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

Local News Publishers